Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377916 | Bioorganic & Medicinal Chemistry Letters | 2006 | 4 Pages |
A series of β-site amyloid precursor protein cleaving enzyme (BACE-1) inhibitors containing a ψ(CH2NH) reduced amide bond were synthesized. Incorporation of this reduced amide isostere as a non-cleavable peptide surrogate afforded inhibitors possessing low nanomolar potencies in both an enzymatic and cell-based assay.
Graphical abstractA new class of β-secretase inhibitors that incorporate a reduced amide transition state isostere as the key binding element is described. The incorporation of a 5-substituted isophthalamide scaffold at the N-terminal site of this isostere resulted in potent compounds that display impressive cellular IC50 values. The syntheses and BACE-1 activities of these inhibitors are reported.Figure optionsDownload full-size imageDownload as PowerPoint slide